We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$73.8B
AUM Growth
-$2.4B
Cap. Flow
-$3.24B
Cap. Flow %
-4.39%
Top 10 Hldgs %
15.79%
Holding
760
New
101
Increased
146
Reduced
447
Closed
46

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.07B
2
CVX icon
Chevron
CVX
+$410M
3
LOW icon
Lowe's Companies
LOW
+$375M
4
BA icon
Boeing
BA
+$328M
5
NTR icon
Nutrien
NTR
+$325M

Sector Composition

Rank Sector Weight
1 Financials 26.81%
2 Industrials 13.57%
3 Healthcare 13.56%
4 Technology 10.01%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNR icon
201
RenaissanceRe
RNR
$13.8B
$83.8M 0.11%
433,379
-23,453
-5% -$4.37M
PM icon
202
Philip Morris
PM
$300B
$83.5M 0.11%
1,099,252
+808,149
+278% +$64M
IPG
203
DELISTED
Interpublic Group of Companies
IPG
$83.2M 0.11%
3,856,600
-716,660
-16% -$15.5M
STLD icon
204
Steel Dynamics
STLD
$33.5B
$82.9M 0.11%
+2,782,747
New +$82.2M
AGN
205
DELISTED
Allergan plc
AGN
$81.4M 0.11%
483,373
-25,970
-5% -$4.23M
CUBE icon
206
CubeSmart
CUBE
$9.03B
$80.5M 0.11%
+2,307,274
New +$80.5M
GNTX icon
207
Gentex
GNTX
$4.83B
$80.5M 0.11%
2,922,107
-1,650,330
-36% -$43.6M
MRVL icon
208
Marvell Technology
MRVL
$200B
$80.4M 0.11%
3,221,292
-628,200
-16% -$15.8M
BSX icon
209
Boston Scientific
BSX
$68B
$79.5M 0.11%
1,952,644
-418,994
-18% -$17.8M
BDC icon
210
Belden
BDC
$4.52B
$79.2M 0.11%
1,484,568
-50,239
-3% -$2.52M
SYNH
211
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$73M 0.1%
1,374,605
-87,707
-6% -$4.5M
TXT icon
212
Textron
TXT
$14.3B
$72.8M 0.1%
1,487,519
+341,641
+30% +$16.7M
TT icon
213
Trane Technologies
TT
$98.9B
$72.5M 0.1%
588,003
+484,218
+467% +$59.1M
FCN icon
214
FTI Consulting
FCN
$4.22B
$72.2M 0.1%
679,349
-14,405
-2% -$1.47M
AUY
215
DELISTED
Yamana Gold, Inc.
AUY
$72M 0.1%
+22,646,761
New +$72.2M
ESNT icon
216
Essent Group
ESNT
$6.23B
$71.1M 0.1%
1,479,966
-60,613
-4% -$2.9M
HUBB icon
217
Hubbell
HUBB
$24.4B
$69.7M 0.09%
530,535
-5,508
-1% -$710K
DKS icon
218
Dick's Sporting Goods
DKS
$12.1B
$68.8M 0.09%
1,686,014
-65,724
-4% -$2.37M
XRX icon
219
Xerox
XRX
$414M
$68.4M 0.09%
2,286,074
-1,628,192
-42% -$51M
PHM icon
220
Pultegroup
PHM
$24.4B
$68.1M 0.09%
1,863,247
-162,306
-8% -$5.4M
VVV icon
221
Valvoline
VVV
$4.09B
$67.2M 0.09%
3,058,214
-59,503
-2% -$1.28M
LNT icon
222
Alliant Energy
LNT
$17.7B
$67.2M 0.09%
1,246,308
+80,410
+7% +$4.13M
EA
223
DELISTED
Electronic Arts
EA
$66.6M 0.09%
+681,324
New +$64M
PNW icon
224
Pinnacle West Capital
PNW
$11.9B
$65M 0.09%
669,739
-1,130,688
-63% -$107M
TTWO icon
225
Take-Two Interactive
TTWO
$44.7B
$62.5M 0.08%
499,113
+31,713
+7% +$3.96M

Similar funds

Boston Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Boston Partners held 760 positions worth $73.8B, down 3.2% from $76.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Boston Partners withdrew a net $3.24B in Q3 2019, closing 46 positions and reducing 447 holdings. Its most notable exit was First Data Corporation, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Boston Partners opened a new position in Lennar Class A worth $369M.

  • Boston Partners's largest Q3 2019 buy was Lennar Class A: 6,821,141 shares worth $369M.
  • Boston Partners added most to JPMorgan Chase in Q3 2019, an estimated $867M increase.
  • Boston Partners's biggest Q3 2019 reduction was Johnson & Johnson, cutting an estimated $1.07B.
  • Boston Partners fully exited First Data Corporation in Q3 2019, selling an estimated $103M.
  • Boston Partners's ten largest holdings make up 16% of its $73.8B portfolio in Q3 2019.
  • Boston Partners opened 101 new positions and closed 46 in Q3 2019.
  • Boston Partners's portfolio value fell 3.2% quarter-over-quarter to $73.8B.

Based on Boston Partners's 13F filing for Q3 2019, filed 8 Nov 2019.